The U.S. Food and Drug Administration has qualified the first artificial intelligence tool designed to help doctors assess a ...
The status could support staged transitions to new manufacturing processes, potentially mitigating some risks of high-stakes ...
An internal memo written by the Food and Drug Administration’s top vaccine regulator offers a concerning glimpse into the future of vaccine regulation in the US — and could have profound implications ...
This approach offers an enhanced therapeutic effect with minimal systemic toxicity, addressing one of oncology’s ...
10hon MSN
US FDA approves first AI tool for liver disease trials: How AIM-NASH transforms biopsy reading
NASH, has received FDA approval to revolutionize liver disease drug trials. This innovative technology assists pathologists ...
Asianet Newsable on MSN
SNTI shares surge over 20% in pre-market trade after FDA RMAT designation for cancer treatment
Senti Biopharma shares rallied in premarket trading on Tuesday after its cancer treatment received a positive designation ...
For traditional approval, CAR T therapies will need to establish superiority over current standard treatments, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback